| |
| |
|
| Insider
Information: |
Stambaugh James |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,000 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intersect Ent, Inc. |
XENT |
|
2016-09-06 |
20,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-09-06 |
4 |
AS |
$16.00 |
$59,200 |
D/D |
(3,700) |
20,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-09-02 |
4 |
AS |
$16.00 |
$4,800 |
D/D |
(300) |
23,700 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-08-03 |
4 |
AS |
$17.00 |
$67,609 |
D/D |
(3,977) |
24,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-08-03 |
4 |
OE |
$0.48 |
$1,909 |
D/D |
3,977 |
27,977 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-07-18 |
4 |
AS |
$15.33 |
$76,643 |
D/D |
(5,000) |
24,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-07-18 |
4 |
OE |
$0.48 |
$2,400 |
D/D |
5,000 |
29,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2016-06-13 |
4 |
S |
$14.38 |
$7,191 |
D/D |
(500) |
24,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2015-11-06 |
4 |
OE |
$0.48 |
$9,600 |
D/D |
20,000 |
24,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2015-09-02 |
4 |
OE |
$0.48 |
$1,920 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2015-07-20 |
4 |
AS |
$30.52 |
$366,209 |
D/D |
(12,000) |
0 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2015-07-20 |
4 |
OE |
$0.48 |
$5,760 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2015-05-08 |
4 |
AS |
$23.87 |
$66,470 |
D/D |
(2,785) |
0 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs |
• – – |
2015-04-01 |
4 |
AS |
$25.50 |
$212,747 |
D/D |
(8,343) |
2,785 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs & Reimb. |
• – – |
2015-03-09 |
4 |
AS |
$23.02 |
$192,030 |
D/D |
(8,343) |
11,128 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
VP Clinical Affairs & Reimb. |
• – – |
2015-02-02 |
4 |
AS |
$20.98 |
$175,004 |
D/D |
(8,343) |
19,471 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
See RemarksOfficer |
• – – |
2014-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,814 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
